Literature DB >> 6370148

Enhanced neutrophil migration in vivo HLA B27 positive subjects.

P Koivuranta-Vaara, H Repo, M Leirisalo, U Kiistala, T Osterman, H Vapaatalo.   

Abstract

Chemotaxis of polymorphonuclear leucocytes in vivo was studied in patients with previous yersinia arthritis and in healthy subjects with or without HLA B27 by means of a skin chamber technique. Irrespective of previous arthritis the number of neutrophils in the chamber media was significantly higher in HLA B27 positive subjects than in those without HLA B27. The amounts of prostaglandins E2, F2 alpha, and 6-keto-F1 alpha in the chamber media correlated positively with the corresponding cell counts. The present results give credence to the view that the hyperreactive neutrophils and the vasodilatory prostaglandins produced by them can together trigger a vicious circle which results in increased inflammatory symptoms in patients with yersinia arthritis who have HLA B27 as compared with those who lack this antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370148      PMCID: PMC1001460          DOI: 10.1136/ard.43.2.181

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Localised leukocyte moblisation in the rabbit ear. An in vivo cell migration technique using plastic collection chambers.

Authors:  C Feurer; J F Borel
Journal:  Antibiot Chemother (1971)       Date:  1974

2.  Suction blister device for separation of viable epidermis from dermis.

Authors:  U Kiistala
Journal:  J Invest Dermatol       Date:  1968-02       Impact factor: 8.551

3.  Macrophages synthesis and release prostaglandins in response to inflammatory stimuli.

Authors:  J L Humes; R J Bonney; L Pelus; M E Dahlgren; S J Sadowski; F A Kuehl; P Davies
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

4.  Reiter's syndrome associated with champylobacter fetus infection.

Authors:  J D Urman; R B Zurier; N F Rothfield
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

5.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

Review 6.  Joseph J. Bunim Memorial Lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease.

Authors:  D A Brewerton
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

7.  Prostacyclin, thromboxane and prostaglandin F2 alpha in suction blister fluid of human skin: effect of systemic aspirin and local glucocorticosteroid treatment.

Authors:  A Oikarinen; L Viinikka; H Rytsälä; U Kiistala; O Ylikorkala
Journal:  Life Sci       Date:  1981-07-27       Impact factor: 5.037

8.  Role of prostaglandin-mediated vasodilatation in inflammation.

Authors:  T J Williams; M J Peck
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

9.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

10.  Stimulation of arachidonic acid metabolism in the polymorphonuclear leukocyte by an N-formylated peptide. Comparison with ionophore A23187.

Authors:  G M Bokoch; P W Reed
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

View more
  11 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Polymorphonuclear leukocyte chemiluminescence response in HLA-B27 positive and negative arthritic patients.

Authors:  R Tertti
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

Authors:  C T Pease; M Fennell; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

4.  Normal production of neutrophil activating peptide 1/interleukin 8 in monocytes from subjects with previous yersinia triggered reactive arthritis.

Authors:  H Repo; M Ristola; M Leirisalo-Repo; A Walz; M Baggiolini
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

5.  Complement activation and HLA-B27.

Authors:  S Meri; J Partanen; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

6.  Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.

Authors:  P Koivuranta-Vaara; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

7.  Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.

Authors:  H Repo; P Koivuranta-Vaara; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

8.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

9.  Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren; P Venge
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

10.  Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.